Antipsychotics and neutropoenia: An update
Annals of Psychiatry and Treatment · 2021
DOI: 10.17352/apt.000027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Psychiatry and Treatment, 2021. Verfasst von Rodríguez Luis Menéndez und 5 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background and objectives: Drugs are a common reason for neutropoenia. The aim of this paper is to review the scientific evidence available in regard to cases of neutropoenia associated with the use of antipsychotics.
Methods
A bibliographic review of the last five years collected in Pubmed, Uptodate, specifications of antipsychotics and the most important Clinical Practice Guidelines, was performed.
Results
The frequency of neutropoenia associated with the use of antipsychotics and agranulocytosis is 3% and 1%, respectively. Neutropoenia is most common during the first three months of treatment. Some risk factors are prior neutropoenia, age, sex, comorbidities or genetic susceptibility. Mortality is extremely rare. Most cases of neutropoenia patients are free of symptoms and they are detected in the laboratory. However, when neutropoenia is severe, the patient can even begin to present sepsis. It is recommended undertaking healthcare education for carers and patients on alarm data. The use of clozapine has a protocol for specific management and monitoring, which reduced the incidence of agranulocytosis and mortality. The incidence of neutropoenia is lower with second and third generation antipsychotics compared to clozapine.
Conclusion
The incidence of neutropoenia with antipsychotics is low. However, it is a potentially severe adverse effect. Blood work up in series needs to be performed during treatment with antipsychotics. It is possible that drugs with major antipsychotic potential such as clozapine are under used because of difficulties with their management and monitoring.
Zitieren
APA
Menéndez, R. L., Angel, M. S. J., Menéndez, R. M., Iglesias, P. A., Fernández, B. S., & Carmen, H. S. M. D. (2021). Antipsychotics and neutropoenia: An update. Annals of Psychiatry and Treatment. https://doi.org/10.17352/apt.000027
Vancouver
Menéndez RL, Angel MSJ, Menéndez RM, Iglesias PA, Fernández BS, Carmen HSMD. Antipsychotics and neutropoenia: An update. Annals of Psychiatry and Treatment. 2021. doi:10.17352/apt.000027
BibTeX
@article{Menndez2021,
author = {Menéndez, Rodríguez Luis and Angel, Méndez Sánchez Jose and Menéndez, Rodríguez Martin and Iglesias, Pérez Antonio and Fernández, Blas Santiago and Carmen, Hernández Sánchez Maria Del},
title = {Antipsychotics and neutropoenia: An update},
journal = {Annals of Psychiatry and Treatment},
year = {2021},
doi = {10.17352/apt.000027}
}
EUVIMED